1-6 of 6
Christopher C. Benz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

Available to Purchase
Angela DeMichele, Douglas Yee, Donald A. Berry, Kathy S. Albain, Christopher C. Benz, Judy Boughey, Meredith Buxton, Stephen K. Chia, Amy J. Chien, Stephen Y. Chui, Amy Clark, Kirsten Edmiston, Anthony D. Elias, Andres Forero-Torres, Tufia C. Haddad, Barbara Haley, Paul Haluska, Nola M. Hylton, Claudine Isaacs, Henry Kaplan, Larissa Korde, Brian Leyland-Jones, Minetta C. Liu, Michelle Melisko, Susan E. Minton, Stacy L. Moulder, Rita Nanda, Olufunmilayo I. Olopade, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Emanuel F. Petricoin, Hope Rugo, Fraser Symmans, Debasish Tripathy, Laura J. van‘t Veer, Rebecca K. Viscusi, Anne Wallace, Denise Wolf, Christina Yau, Laura J. Esserman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (13): 2911–2915.
https://doi.org/10.1158/1078-0432.CCR-14-1760
Published: 30 June 2015
View articletitled, The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Open the PDF for The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer in another window
Journal Articles

Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer

Free
Filippa Pettersson, Christina Yau, Monica C. Dobocan, Biljana Culjkovic-Kraljacic, Hélène Retrouvay, Rachel Puckett, Ludmila M. Flores, Ian E. Krop, Caroline Rousseau, Eftihia Cocolakis, Katherine L. B. Borden, Christopher C. Benz, Wilson H. Miller, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2874–2884.
https://doi.org/10.1158/1078-0432.CCR-10-2334
Published: 01 May 2011
View articletitled, Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer
Open the PDF for Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression

Available to Purchase
Junko Suzuki, Yunn-Yi Chen, Gary K. Scott, Sandy DeVries, Koei Chin, Christopher C. Benz, Frederic M. Waldman, E. Shelley Hwang
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3163–3171.
https://doi.org/10.1158/1078-0432.CCR-08-2319
Published: 30 April 2009
View articletitled, Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression
Open the PDF for Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression in another window
Includes: Supplementary data
Journal Articles

Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes

Available to Purchase
Daryl C. Drummond, Corina Marx, Zexiong Guo, Gary Scott, Charles Noble, Donghui Wang, Maria Pallavicini, John W. Park, Dmitri B. Kirpotin, Christopher C. Benz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3392–3401.
https://doi.org/10.1158/1078-0432.CCR-04-2445
Published: 02 May 2005
View articletitled, Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes
Open the PDF for Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes in another window
Journal Articles

Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery

Available to Purchase
John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, Jose Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks, Dan Moore, Demetrios Papahadjopoulos, Christopher C. Benz
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1172–1181.
Published: 01 April 2002
View articletitled, Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery
Open the PDF for Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery in another window
Journal Articles

Increased Activator Protein-1 DNA Binding and c-Jun NH2-Terminal Kinase Activity in Human Breast Tumors with Acquired Tamoxifen Resistance

Available to Purchase
Stephen R. D. Johnston, Biao Lu, Gary K. Scott, Peter J. Kushner, Ian E. Smith, Mitchell Dowsett, Christopher C. Benz
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 251–256.
Published: 01 February 1999
View articletitled, Increased Activator Protein-1 DNA Binding and c-Jun NH2-Terminal Kinase Activity in Human Breast Tumors with Acquired Tamoxifen Resistance
Open the PDF for Increased Activator Protein-1 DNA Binding and c-Jun NH2-Terminal Kinase Activity in Human Breast Tumors with Acquired Tamoxifen Resistance in another window